نتائج البحث - Reshma Singh

  • يعرض 1 - 7 نتائج من 7
تنقيح النتائج
  1. 1
    Defective Cross-Presentation of Viral Antigens in GILT-Free Mice

    Defective Cross-Presentation of Viral Antigens in GILT-Free Mice حسب Reshma Singh, Peter Cresswell

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    GILT is a critical host factor for Listeria monocytogenes infection

    GILT is a critical host factor for Listeria monocytogenes infection حسب Reshma Singh, A. M. Jamieson, Peter Cresswell

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Fusion to Listeriolysin O and Delivery by <i>Listeria monocytogenes</i> Enhances the Immunogenicity of HER-2/neu and Reveals Subdominant Epitopes in the FVB/N Mouse

    Fusion to Listeriolysin O and Delivery by <i>Listeria monocytogenes</i> Enhances the Immunogenicity of HER-2/neu and Reveals Subdominant Epitopes in the FVB/N Mouse حسب Reshma Singh, Mary E. Dominiecki, Elizabeth M. Jaffee, Yvonne Paterson

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    <i>Lm</i>-LLO-Based Immunotherapies and HPV-Associated Disease

    <i>Lm</i>-LLO-Based Immunotherapies and HPV-Associated Disease حسب Anu Wallecha, Chris A. French, Robert G. Petit, Reshma Singh, Ashok R. Amin, John Rothman

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy

    Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy حسب Mikayel Mkrtichyan, Namju Chong, Rasha Abu Eid, Anu Wallecha, Reshma Singh, John Rothman, Samir N. Khleif

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma

    Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma حسب Dexiu Bu, Reshma Singh, Eugene Choi, Marco Ruella, Selene Nuñez-Cruz, Keith G. Mansfield, Paul M. Bennett, Nathanial Barton, Qilong Wu, Jiquan Zhang, Yongqiang Wang, Lai Wei, Shawn Cogan, Tucker Ezell, Shree Joshi, Kellie Latimer, Brian Granda, William R. Tschantz, Regina M. Young, Heather Huet, Celeste Richardson, Michael C. Milone

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma

    Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma حسب Laura A. Johnson, John Scholler, Takayuki Ohkuri, Akemi Kosaka, Prachi Patel, Shannon E. McGettigan, Arben Nace, Tzvete Dentchev, Pramod Thekkat, Andreas Loew, Alina C. Boesteanu, Alexandria P. Cogdill, Taylor Chen, Joseph A. Fraietta, Christopher C. Kloss, Avery D. Posey, Boris Engels, Reshma Singh, Tucker Ezell, Neeraja Idamakanti, Melissa Ramones, Na Li, Li Zhou, Gabriela Plesa, John T. Seykora, Hideho Okada, Carl H. June, Jennifer L. Brogdon, Marcela V. Maus

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: